Challenging Renal Cases 2018
Christopher G. Wood, M.D., F.A.C.S. Professor, Department of Urology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX chairs an esteem panel to discuss challenging ...
Author: kidneycancer
Added: 05/03/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 3, 2018 Category: Cancer & Oncology Source Type: podcasts
Novel ALL treatment strategies: inotuzumab ozogamicin
Over the past year, several exciting new agents for the treatment of acute lymphoblastic leukemia (ALL) have been approved. In this interview, Elias Jabbour, MD, of the University of Texas MD Anderson...
Author: VJHemOnc
Added: 02/22/2018 (Source: Oncology Tube)
Source: Oncology Tube - February 22, 2018 Category: Cancer & Oncology Source Type: podcasts
Triple therapy including nivolumab for newly diagnosed AML
Farhad Ravandi, MD, from the University of Texas MD Anderson Cancer Center, Houston, TX, provides an overview of the pilot Phase II study (NCT02464657) of cytarabine, idarubicin and the PD-1 inhibitor...
Author: VJHemOnc
Added: 02/09/2018 (Source: Oncology Tube)
Source: Oncology Tube - February 9, 2018 Category: Cancer & Oncology Source Type: podcasts
Multiple Myeloma studies for 2018 Data from Daratumumab with carfilzomib, lenalidomide etc
Robert Z. Orlowski, MD, PhD, from The University of Texas MD Anderson Cancer Center discusses multiple myeloma studies for 2018 data from daratumumab with carfilzomib, lenalidomide etc at the 2017 Ame...
Author: ASHReport
Added: 01/11/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 11, 2018 Category: Cancer & Oncology Source Type: podcasts
Combinations Well Tolerated in Multiple Myeloma Benefits are better when compared to lenalidomide alone
Robert Z. Orlowski, MD, PhD, from The University of Texas MD Anderson Cancer Center discusses combinations well tolerated in multiple Myeloma and that benefits are better when compared to lenalidomide...
Author: ASHReport
Added: 01/10/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 10, 2018 Category: Cancer & Oncology Source Type: podcasts
Axi-Cel is a milestone for treating B-Cell Lymphoma Paradigm shift for future B-Cell Lymphoma treatment
Sattva S. Neelapu, MD, from the University of Texas MD Anderson Cancer Center discusses how Axi-Cel is a milestone for treating B-Cell Lymphoma and the paradigm shift for future B-Cell Lymphoma treatm...
Author: ASHReport
Added: 01/10/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 10, 2018 Category: Cancer & Oncology Source Type: podcasts
May the force be with you: the power of next-generation sequencing
Clinical access to new technologies, such as next-generation sequencing (NGS), can revolutionize the treatment of cancer. In this interview, Guillermo Garcia-Manero, MD, of the University of Texas MD ...
Author: VJHemOnc
Added: 01/08/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 8, 2018 Category: Cancer & Oncology Source Type: podcasts
Safety profile of anti-CD19 CAR T-cell therapy axicabtagene ciloleucel
A major concern surrounding novel therapeutics is their safety, which must be characterized thoroughly. Here, Sattva Neelapu, MD, from the University of Texas MD Anderson Cancer Center, Houston, TX, d...
Author: VJHemOnc
Added: 01/05/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 5, 2018 Category: Cancer & Oncology Source Type: podcasts
Can Sunlight Reduce Fatigue From Cancer?
Cancer fatigue is a common complaint with cancer patients, but what can be done to reduce this troublesome synmptom? Andrew Schorr, Dr. Ishwaria M. Subbiah of The University of Texas MD Anderson Cance...
Author: patientpower
Added: 12/29/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 29, 2017 Category: Cancer & Oncology Source Type: podcasts
Palliative Care vs. Supportive Care: Whats the Difference?
How do you define palliative medicine today? Andrew Schorr and lung cancer experts Dr. Ishwaria Subbiah of The University of Texas MD Anderson Cancer Center and Dr. Christine Lovly of Vanderbilt-Ingra...
Author: patientpower
Added: 12/22/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 23, 2017 Category: Cancer & Oncology Source Type: podcasts
Could CLL and Its Treatment Affect Male Fertility?
Could CLL affect fertility in men and does it reduce the quality of sperm? Dr. Michael Keating, a world-renowned CLL expert from The University of Texas MD Anderson Cancer Center, identifies the ferti...
Author: patientpower
Added: 12/15/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 16, 2017 Category: Cancer & Oncology Source Type: podcasts
Side effects of novel PI3K inhibitors
Nathan Fowler, MD, from the University of Texas MD Anderson Cancer Center, Houston, TX, discusses side effects of PI3K inhibitors at the 2017 International Workshop in Non-Hodgkin Lymphoma (iwNHL) in ...
Author: VJHemOnc
Added: 11/17/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 17, 2017 Category: Cancer & Oncology Source Type: podcasts
Ask the Expert: How Do Steroids Affect CLL Treatment Response?
Steroids can be used as a part of a CLL patients treatment regimen, but how do they influence the bodys ability to reach remission? Dr. Michael Keating, a leading expert from The University of Texas...
Author: patientpower
Added: 11/16/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 16, 2017 Category: Cancer & Oncology Source Type: podcasts
